Association between timely targeted treatment and outcomes in patients with metastatic HER2‐overexpressing gastroesophageal adenocarcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34117
Abstract: Timely targeted treatment initiation can be challenging because additional biomarker testing is needed for eligibility. The authors hypothesized that timely targeted treatment improves survival relative to nontimely initiation in metastatic HER2+ gastroesophageal adenocarcinoma (GEA). read more here.
Keywords: gastroesophageal adenocarcinoma; metastatic her2; timely targeted; targeted treatment ... See more keywords
Use of Taxanes in Metastatic HER2-negative Breast Cancer – a Status Report
Sign Up to like & getrecommendations! Published in 2020 at "Geburtshilfe und Frauenheilkunde"
DOI: 10.1055/a-1126-4247
Abstract: The most important goal of treatment of patients with metastatic breast cancer is maintenance or even improvement of quality of life. In this setting, chemotherapy should be used with as much restraint as possible. If… read more here.
Keywords: metastatic her2; taxanes metastatic; breast; breast cancer ... See more keywords
Phase II study of eribulin with trasutuzumab for pretreated locally advanced or metastatic HER2-positive breast cancer.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e12505
Abstract: e12505Background: Eribulin mesylate demonstrated a survival benefit in patients with locally recurrent or metastatic breast cancer who previously received 2 or more chemotherapy regimens. There are limited studies reported about the efficacy of eribulin with… read more here.
Keywords: advanced metastatic; metastatic her2; breast; breast cancer ... See more keywords
Developments in the Management of Metastatic HER2-Positive Breast Cancer: A Review
Sign Up to like & getrecommendations! Published in 2022 at "Current Oncology"
DOI: 10.3390/curroncol29040208
Abstract: Approximately 20% of breast cancers overexpress human epidermal growth factor receptor 2 (HER2), providing an actionable target for many different therapies. In the metastatic setting, prognosis has improved greatly with the use of anti-HER2 drugs… read more here.
Keywords: management metastatic; her2; metastatic her2; her2 positive ... See more keywords